Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn

Olivia Bennett
1 Min Read
Advertisement

UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds

Advertisement

The pipeline of new drugs to fight superbugs remains “worryingly thin” and has shrunk by 35% in the last five years, experts have said, predicting the annual number of deaths linked to drug-resistant infections globally will double to 8 million by 2050.

Advertisement

The number of antimicrobial projects from large pharma companies has shrunk by 35% over the past five years, from 92 to 60 medicines in development, according to a report from the Access to Medicine Foundation (AMF), a Netherlands-based non-profit group, backed by the Wellcome Trust. Only five medicines are in development for children under five, who are more vulnerable to infections.


This article was curated and published by
Health Guidance Hub.

Advertisement

https://healthguidancehub.space/

Share This Article
Follow:
Olivia Bennett (she/her) is a health education specialist and medical writer dedicated to providing clear, evidence-based health information. She holds a strong academic background in public health and clinical sciences, with advanced training from respected institutions in the United States and the United Kingdom.   Bennett earned her Bachelor of Science in Public Health from the University of Michigan. She later completed her Doctor of Medicine (MD) at the Johns Hopkins University School of Medicine, where she developed a deep interest in preventive care and patient education.   To further strengthen her expertise in global and community health, she obtained a Master of Science in Global Health and Development from the University College London. She also completed a Postgraduate Certificate in Clinical Nutrition at the King's College London.   Since completing her studies, Bennett has worked in both clinical and health communication roles, contributing to medical blogs, health platforms, and public awareness campaigns. Her work focuses on translating complex medical research into practical guidance that everyday readers can understand and apply.   In 2021, she began specializing in digital health education, helping online health platforms maintain medically accurate, reader-friendly content. Her key areas of focus include: Preventive healthcare Women’s health Mental health awareness Chronic disease management (diabetes, hypertension) Nutrition and lifestyle medicine   Bennett believes that trustworthy health information should be accessible to everyone. Her goal is to empower readers to make informed decisions about their well-being through clear, compassionate, and research-backed guidance.   Outside of her professional work, she enjoys reading medical journals, participating in community wellness initiatives, and mentoring aspiring health writers.
Leave a Comment